Clinical trial · Observational
A Multicenter Cross-sectional Study on Mental Health of Patients With Multiple Myeloma
NCT05620420CI-TRIAL-00082995completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Multiple myeloma patients with normal ability of communication and understanding will be enrolled. DT, GAD-7, PHQ-15 and PSQI scales are designed to assess the mental health status of the patients. Demographic and disease data of patients will be collected as well. The main aim is to explore the factors affecting the mental health of myeloma patients.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Insomnia | — | UNRESOLVED | — |
| Psychological Distress | — | UNRESOLVED | — |
| Somatic Symptoms | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- morbidity of psychological distress in patients with multiple myeloma.
- timeFrame
- Baseline (the time when the patient is enrolled to the study)
- description
- The total score of DT scale ≥4 points is defined as obviously psychological distress.
Secondary outcomes (2)
- measure
- morbidity of anxiety in patients with multiple myeloma.
- timeFrame
- Baseline (the time when the patient is enrolled to the study)
- description
- GAD-7 scale is applied to assess the anxiety of the patient
- measure
- morbidity of insomnia in patients with multiple myeloma.
- timeFrame
- Baseline (the time when the patient is enrolled to the study)
- description
- PSQI scale is applied to assess the insomnia of the patient
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Patients with symptomatic multiple myeloma were diagnosed according to the criteria of Chinese multiple myeloma diagnosis and treatment guidelines (revised in 2022). 2. Age ≥18 years, with junior high school education or above. Patients have normal ability of communication and understanding. 3. Informed consent has been signed. Exclusion Criteria: 1. Who has kinship with other enrolled patients. 2. Life expectancy of\< 6 months.
References
Publications (0)
Data not yet available
No reference posted for this study.